196 related articles for article (PubMed ID: 34674340)
1. Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey.
Kim M; Cheol Lim M; Ji Nam E; Huang D; Kim S; Jong Yoo H; Lee YY; Chang YJ;
J Genet Couns; 2022 Apr; 31(2):546-553. PubMed ID: 34674340
[TBL] [Abstract][Full Text] [Related]
2. Practice Patterns of Hereditary Ovarian Cancer Management in Korea.
Choi MC; Lim MC; Lee M; Kim MK; Suh DH; Song YJ; Kim TJ; Chang SJ; Kim JW
Int J Gynecol Cancer; 2017 Jun; 27(5):895-899. PubMed ID: 28498247
[TBL] [Abstract][Full Text] [Related]
3. Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.
Liang MI; Wong DH; Walsh CS; Farias-Eisner R; Cohen JG
J Genet Couns; 2018 Feb; 27(1):177-186. PubMed ID: 28785836
[TBL] [Abstract][Full Text] [Related]
4. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Randall LM; Pothuri B; Swisher EM; Diaz JP; Buchanan A; Witkop CT; Bethan Powell C; Smith EB; Robson ME; Boyd J; Coleman RL; Lu K
Gynecol Oncol; 2017 Aug; 146(2):217-224. PubMed ID: 28596016
[TBL] [Abstract][Full Text] [Related]
5. Genetic predisposition in gynecologic cancers.
Daniels MS; Lu KH
Semin Oncol; 2016 Oct; 43(5):543-547. PubMed ID: 27899185
[TBL] [Abstract][Full Text] [Related]
6. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
[TBL] [Abstract][Full Text] [Related]
7. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Chen LM; Richardson DL;
Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
[TBL] [Abstract][Full Text] [Related]
8. Management of genetic syndromes predisposing to gynecologic cancers.
Miesfeldt S; Lamb A; Duarte C
Curr Treat Options Oncol; 2013 Mar; 14(1):34-50. PubMed ID: 23315239
[TBL] [Abstract][Full Text] [Related]
9. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.
Masuda K; Hirasawa A; Irie-Kunitomi H; Akahane T; Ueki A; Kobayashi Y; Yamagami W; Nomura H; Kataoka F; Tominaga E; Banno K; Susumu N; Aoki D
Jpn J Clin Oncol; 2017 May; 47(5):401-406. PubMed ID: 28334914
[TBL] [Abstract][Full Text] [Related]
11. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
12. A survey of the practice patterns of gynecologic oncologists dealing with hereditary cancer patients in Japan.
Tanabe N; Shikama A; Bando H; Satoh T; Shimizu C
Fam Cancer; 2014 Sep; 13(3):489-98. PubMed ID: 24853694
[TBL] [Abstract][Full Text] [Related]
13. Hereditary gynecologic cancers.
Mutch D; Denny L; Quinn M;
Int J Gynaecol Obstet; 2014 Mar; 124(3):189-92. PubMed ID: 24429354
[No Abstract] [Full Text] [Related]
14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
15. Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.
Morgan D; Sylvester H; Lucas FL; Miesfeldt S
Fam Cancer; 2009; 8(4):277-87. PubMed ID: 19347608
[TBL] [Abstract][Full Text] [Related]
16. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
Lu KH
Fam Cancer; 2008; 7(1):53-8. PubMed ID: 17636427
[TBL] [Abstract][Full Text] [Related]
17. Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome.
De Simone LM; Arjunan A; Vogel Postula KJ; Maga T; Bucheit LA
J Genet Couns; 2021 Feb; 30(1):158-169. PubMed ID: 32562467
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
19. Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
Powell CB; Laurent C; Ciaravino G; Garcia C; Han L; Hoodfar E; Karlea A; Kobelka C; Lee J; Littell RD; Roh J; Vay A; Kushi LH
Gynecol Oncol; 2020 Oct; 159(1):221-228. PubMed ID: 32778409
[TBL] [Abstract][Full Text] [Related]
20. Impact of Implementing B-RST
Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
